BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 2081480)

  • 1. Traditional management of liver disorders.
    Messner M; Brissot P
    Drugs; 1990; 40 Suppl 3():45-57. PubMed ID: 2081480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver cirrhosis with ascites: pathogenesis of resistance to diuretics and long-term efficacy and safety of torasemide.
    Knauf H; Mutschler E
    Cardiology; 1994; 84 Suppl 2():87-98. PubMed ID: 7954550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of diuretics in the treatment of ascites in patients with cirrhosis].
    Bourgeois N; Devaere S; Adler M; Cremer M
    Acta Gastroenterol Belg; 1990; 53(2):256-60. PubMed ID: 2267905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy of ascites associated with cirrhosis.
    Ginès P; Arrovo V; Rodés J
    Drugs; 1992 Mar; 43(3):316-32. PubMed ID: 1374317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term treatment of chronic hepatitis and liver cirrhosis].
    Pusch JH; Ullmann W
    Med Klin; 1975 Apr; 70(15):674-81. PubMed ID: 806771
    [No Abstract]   [Full Text] [Related]  

  • 6. Medical management of chronic liver diseases (CLD) in children (part II): focus on the complications of CLD, and CLD that require special considerations.
    El-Shabrawi MH; Kamal NM
    Paediatr Drugs; 2011 Dec; 13(6):371-83. PubMed ID: 21999650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
    Arroyo V; Ginès P; Planas R
    Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients.
    Gatta A; Angeli P; Caregaro L; Menon F; Sacerdoti D; Merkel C
    Hepatology; 1991 Aug; 14(2):231-6. PubMed ID: 1860680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Kosta P; Papadimitriou K; Tsianos EV
    J Clin Gastroenterol; 2006 Apr; 40(4):342-6. PubMed ID: 16633107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hyponatremic cirrhosis with ascites resistant to diuretics by urea.
    Decaux G; Mols P; Cauchie P; Flamion B; Delwiche F
    Nephron; 1986; 44(4):337-43. PubMed ID: 3796773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.
    Ward A; Heel RC
    Drugs; 1984 Nov; 28(5):426-64. PubMed ID: 6391889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Main characteristics of the treatment of liver cirrhosis].
    Mörl M
    Ther Ggw; 1981 May; 120(5):422-41. PubMed ID: 7233355
    [No Abstract]   [Full Text] [Related]  

  • 13. An optimal diuretic regimen for cirrhotic ascites. A controlled trial evaluating safety and efficacy of spironolactone and furosemide.
    Fuller RK; Khambatta PB; Gobezie GC
    JAMA; 1977 Mar; 237(10):972-5. PubMed ID: 319263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of action of xipamide and its classification as a "low ceiling diuretic". Pharmacodynamic-pharmacokinetic studies in healthy volunteers and in kidney and liver patients].
    Knauf H; Mutschler E
    Arzneimittelforschung; 2005; 55(1):1-14. PubMed ID: 15727159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of cirrhotic ascites.
    Schouten J; Michielsen PP
    Acta Gastroenterol Belg; 2007; 70(2):217-22. PubMed ID: 17715638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutrition management in chronic liver disease.
    Bavdekar A; Bhave S; Pandit A
    Indian J Pediatr; 2002 May; 69(5):427-31. PubMed ID: 12061678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent advances in the treatment of decompensated liver cirrhosis].
    Moriwaki H; Kato M; Murase M; Muto Y
    Nihon Rinsho; 1994 Jan; 52(1):192-6. PubMed ID: 8114292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of cirrhotic ascites.
    Alaniz C
    Clin Pharm; 1989 Sep; 8(9):645-54. PubMed ID: 2676316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of six treatments of ascites in patients with liver cirrhosis. A clinical trial.
    Descos L; Gauthier A; Levy VG; Michel H; Quinton A; Rueff B; Fermanian J; Fombonne E; Durbec JP
    Hepatogastroenterology; 1983 Feb; 30(1):15-20. PubMed ID: 6339343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of liver disease in dogs and cats.
    Tams TR
    Mod Vet Pract; 1984 Feb; 65(2):107-14. PubMed ID: 6727841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.